Neonatal TPN Starter Bags Recalled Due to Sterility Validation Failure
Central Admixture Pharmacy Services is recalling 356 neonatal TPN starter bags due to lack of validation data for decontamination cycles. The sterility of the affected lots cannot be assured.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a sterility assurance failure for a critical neonatal parenteral medication product. Although no illnesses or injuries are reported, the theoretical risk of contamination in a product designed for vulnerable neonatal patients constitutes a risk-of-harm scenario meeting the High severity criterion.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 356 neonatal TPN (Total Parenteral Nutrition) Starter Bags. The recalled product contains Trophamine 3% Amino Acids and Dextrose 10% in 250 mL IV bags. The manufacturer is located at 2200 South 43rd Avenue, Phoenix, Arizona 85043.
The recall is due to lack of assurance of sterility. The validation data for decontamination cycles is lacking, meaning the sterility of the affected product cannot be confirmed. The affected lots are Lot 36-251326 (Expiration 7/13/2023), Lot 36-251451 (Expiration 7/14/2023), and Lot 36-254915 (Expiration 7/22/2023).
The product was distributed nationwide throughout the United States. This is a prescription-only medication intended for neonatal patients requiring parenteral nutrition support.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10%, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0404-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- lack-of-sterility
- inadequate-decontamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: 36-251326
- Exp. 7/13/2023
- 36-251451
- Exp. 7/14/2023
- 36-254915
- Exp. 7/22/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27